Dr Ed Schwalbe
Dr Janet Lindsey
Dr Marina Danilenko
Dr Rebecca Hill
Dr Stephen Crosier
et al. | Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study | 2025 |
|
Jemma Castle
Dr Edward Fielder
Mankaran Singh
Professor Roderick Skinner
Professor Thomas von Zglinicki
et al. | In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastoma | 2024 |
|
Dr Edward Fielder
Abbas Ishaq
Evon Low
Aisha Calista
Jemma Castle
et al. | Mild Uncoupling of Mitochondria Synergistically Enhances Senolytic Specificity and Sensitivity of BH3 Mimetics | 2024 |
|
Dr Edward Fielder
Abbas Ishaq
Evon Low
Joseph Laws
Aisha Calista
et al. | Mild Uncoupling of Mitochondria Synergistically Enhances Senolytic Specificity and Sensitivity of BH3 Mimetics | 2024 |
|
Dr Jack Goddard
Jemma Castle
Emily Southworth
Anya Fletcher
Dr Stephen Crosier
et al. | MEDB-71. Molecular characterisation of Group 4 medulloblastoma improves risk-stratification and its biological understanding | 2022 |
|
Dr Daniel Williamson
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Janet Lindsey
Dr Stephen Crosier
et al. | Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development | 2022 |
|
